Trademark: 90844780
Word
REYPOINT
Status
Pending
Status Code
731
Status Date
Thursday, March 14, 2024
Serial Number
90844780
Mark Type
4000
Filing Date
Friday, July 23, 2021
Published for Opposition
Tuesday, February 21, 2023

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use

Trademark Events
Mar 15, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 14, 2024
Sou Extension 2 Granted
Mar 14, 2024
Sou Extension 2 Filed
Mar 14, 2024
Sou Teas Extension Received
Oct 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 3, 2023
Sou Extension 1 Granted
Oct 3, 2023
Sou Extension 1 Filed
Oct 3, 2023
Sou Teas Extension Received
Aug 2, 2023
Teas Change Of Correspondence Received
Aug 2, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 2, 2023
Teas Change Of Owner Address Received
Apr 18, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 21, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2023
Published For Opposition
Feb 1, 2023
Notification Of Notice Of Publication E-Mailed
Jan 18, 2023
Approved For Pub - Principal Register
Jan 11, 2023
Teas/Email Correspondence Entered
Jan 11, 2023
Correspondence Received In Law Office
Jan 11, 2023
Assigned To Lie
Nov 15, 2022
Notice Of Revival - E-Mailed
Nov 14, 2022
Teas Response To Office Action Received
Nov 14, 2022
Petition To Revive-Granted
Nov 14, 2022
Teas Petition To Revive Received
Nov 9, 2022
Abandonment Notice E-Mailed - Failure To Respond
Nov 9, 2022
Abandonment Notice Mailed - Failure To Respond
Nov 9, 2022
Abandonment - Failure To Respond Or Late Response
Apr 26, 2022
Notification Of Non-Final Action E-Mailed
Apr 26, 2022
Non-Final Action E-Mailed
Apr 26, 2022
Non-Final Action Written
Apr 19, 2022
Assigned To Examiner
Sep 23, 2021
New Application Office Supplied Data Entered
Jul 27, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24